~~<i id='A0F9C40894'><strike id='A0F9C40894'><tt id='A0F9C40894'><pre id='A0F9C40894'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

author：leisure time 2025-09-30 20:20:17 - browse：54313

Martin Shkreli Securities Fraud Trial — Kevin Hagen/Getty Images

Is this the end of the line for the “pharma bro” with the perpetual smirk?

Martin Skhreli was found guilty on Friday of three counts of fraud after a five-week trial in federal court in Brooklyn, N.Y. He faces a prison sentence that could stretch years.

“This was a witch hunt of epic proportions,” Shkreli said outside court after the verdict, the Washington Post reported. “They may have found some broomsticks.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Readout Newsletter: Amylyx, Aurinia, and IQVIA

explore

hotspot

explore

entertainment

explore

AdobeAgrowingbodyofdatashowthatSouthAsiansareatgreaterriskofdevelopingheartdiseasethanwhitepeople,an

WSS

Industry veterans launch new biotech VC with $310M

AMAs digital advisors table RPM coding reform proposal, again

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Eli Lilly reports tirzepatide MASH success during Q4 earnings

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

focus

focus

explore

Dobbs anniversary: the lost opportunity of abortion as health care

Latigo launches with $135 million for Vertex

Bright Health sells Medicare Advantage business to Molina

Tome Biosciences co

Anesthesiologist group: stop taking Ozempic before surgery

Artificial intelligence use in health care faces greater scrutiny in 2024

Apple is now the first public company to be valued at $3 trillion

Resistance to opioid

United colonoscopy coverage change 'may cost lives,' doctors say

Congress must protect the remaining independent doctors

hotspot

Industry veterans launch new biotech VC with $310M

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Congress must protect the remaining independent doctors

Why Eli Lilly’s earnings didn’t quite live up to the hype

ACIP vaccine advisory panel sees its vacancies filled

ACIP vaccine advisory panel sees its vacancies filled

explore

entertainment

explore

explore